Home > Insider Trading > Filing (0001179110-19-006055)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1579428	Axsome Therapeutics Inc.	AXSM	Pharmaceutical Preparations (2834)	454241907

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1658379	Mark Coleman	C/O Axsome Therapeutics, Inc. 200 Broadway, 3Rd Floor New York NY 10038		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-05-13	4,650	$21.44	652,648	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,100	Indirect	See Footnote

Footnotes

The price reported in Column 4 is an average price. These shares were purchased by the reporting person in multiple transactions at prices ranging from $21.42 to $21.49, inclusive. The reporting person undertakes to provide to Axsome Therapeutics, Inc., the staff of the Securities and Exchange Commission, and others pursuant to applicable securities laws, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (1) to this Form 4.
Represents additional shares held indirectly by the reporting person prior to May 13, 2019. See Footnote 3.
Such shares were purchased by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.